Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 9, 2009 - Issue 3
Submit an article Journal homepage
108
Views
1
CrossRef citations to date
0
Altmetric
Review

Recent perspectives on the genetic background of neural tube defects with special regard to iniencephaly

József Gábor Joó 1st Department of Obstetrics and Gynecology, Faculty of General Medicine, Semmelweis University, 1088 Budapest, Baross utca 27, Hungary. [email protected]
Pages 281-293 | Published online: 09 Jan 2014

References

  • Milunksy A, Canick JA. Maternal serum screening for neural tube defects. In: Genetic Disorders and the Fetus. Milunsky A (Ed.). Johns Hopkins University Press, MD, USA and London, UK, 719–794 (2004).
  • Jones KL. Meningomyelocele, anencephaly, iniencephaly sequences. In: Smith’s Recognizable Patterns of Human Malformation. Jones KL (Ed.). WB Saunders Company, PA, USA, 608–609 (1997).
  • Botto LD, Moore CA, Khoury MJ, Erikson JD. Neural tube defects. N. Engl. J. Med.341, 1509–1519 (1999).
  • Hunter AGW. Brain and spinal cord. In: Human Malformations and Related Anomalies Vol. 2. Oxford Monographs on Medical Genetics No. 27. Stevenson RE, Hall JG, Goodman RM (Eds). University Press, NY, USA and Oxford, UK, 109–137 (1993).
  • Joó JG, Beke A, Papp C et al. Major diagnostic and pathological features of iniencephaly based on twenty-four cases. Fetal Diag. Ther.24, 1–6 (2008).
  • Szabó I, Papp Z. Craniospinal malformations. In: Klinikai Genetika. Papp Z (Ed.). Golden Book Kiadó, 515–522 (1995).
  • Morocz I, Szeifert GT, Molnár P et al. Prenatal diagnosis and pathoanatomy of iniencephaly. Clin. Genet.30, 81–86 (1986).
  • Katz VL, Aylsworth AS, Albright SG. Iniencephaly is not uniformly fatal. Prenat. Diagn.9, 595–599 (1989).
  • Tóth Z. The prenatal diagnostics of iniencephaly. Ideggyógy. Sz.35, 859–864 (1982).
  • Meizner I, Levi A, Katz M, Maor E. Iniencephaly. A case report. J. Reprod. Med.37, 885–888 (1992).
  • Romero R, Pilu G, Jeanty P. Prenatal diagnosis of congenital anomalies. Appleton & Lange, Norwalk, CT, USA (1988).
  • Dogan MM, Ekici E, Yapar EG et al. Iniencephaly: sonographic-pathologic correlation of 19 cases. J. Perinat. Med.24, 501–511 (1996).
  • Chaurasia BD, Wagh KV, Goyal J. Spinal retroflexion in craniorachischisis: its classification and limitation. Acta Anat.94, 626–632 (1976).
  • Csabay L, Szabó I, Papp C, Tóth-Pál E, Papp Z. Central nervous system anomalies. Ann. NY Acad. Sci.847, 21–45 (1998).
  • Stark AM. A report of two cases of iniencephalus. Br. J. Obstet. Gynecol.58, 462–464 (1951).
  • Papp Z. 1992. Neural tube defects. In: Atlas of Fetal Diagnosis. Papp Z (Ed.). Elsevier, Amsterdam, The Netherlands 117–137 (1992).
  • Gardner WJ. Klippel-Feil syndrome, iniencephalus, anencephalus, hindbrain hernia and mirror movements: overdistension of the neural tube. Child’s Brain5, 361–379 (1979).
  • Aleksic S, Budzilovich G, Greco MA. Iniencephaly: neuropathologic study. Clin. Neuropathol.2, 55–61 (1983).
  • Main DM, Menutti MT. Neural tube defects: issues in prenatal diagnoses and counselling Obstet. Gynecol.67, 1–16 (1980).
  • Holmes LB, Shirley MD, Driscoll G, Atkins L. Etiologic heterogeneity of neural tube defects. N. Eng. J. Med.294, 365–369 (1976).
  • Frey L, Hauser WA. Epidemiology of neural tube defects. Epilepsia44(Suppl. 3), 4–13 (2003).
  • Papp Z. The Semmelweis University experience. Fetal Diagn. Ther.17, 258–267 (2002).
  • De Marco P, Merello E, Mascelli S, Capra V. Current perspectives on the genetic causes of neural tube defects. Neurogenetics7, 201–221 (2006).
  • O’Rahilly R, Muller F. The two sites of fusion of the neural folds and the two neuropores in the human embryo. Teratology65, 162–170 (2002).
  • Copp AJ, Greene NDE, Murdoch JN. The genetic basis of mammalian neurulation. Nat. Rev. Genet.4, 784–793 (2003).
  • Juriloff DM, Harris MJ, Tom C, MacDonald KB. Normal mouse strains differ in the site of initiation of closure of the cranial neural tube. Teratology44, 225–233 (1991).
  • Van Allen MI, Kalousek DK, Chernoff GF et al. Evidence for multi-site closure of the neural tube in humans. Am. J. Med. Genet.47, 723–743 (1993).
  • Nakatsu T, Uwabe C, Shiota K. Neural tube closure in humans initiates at multiple sites: evidence from human embryos and implications for the pathogenesis of neural tube defects. Anat. Embryol. (Berl.)201, 455–466 (2000).
  • Colas JF, Schoenwolf GC. Towards a cellular and molecular understanding of neurulation. Nat. Rev. Genet.4, 784–793 (2003).
  • Gordon R. A review of the theories of vertebrate neurulation and their relationship to the mechanics of neural tube birth defects. J. Embryol. Exp. Morphol.89, 229–255 (1985).
  • Kolatsi-Joannu M, Moore R, Winyard PJ, Woolf AS. Expression of hepatocyte growth factor/scatter factor and its receptor, MET suggests roles in human embryonic organogenesis. Pediatr. Res.41, 657–665 (1997).
  • Wang Y, Selden C, Farnaud S et al. Hepatocyte growth factor (HGF/SF) is expressed in human epithelial cells during embryonic development; studies by in situ hibridisation and northern blot analysis. J. Anat.185, 543–551 (1994).
  • Piscione TD, Rosenblum ND. The molecular control of renal branching morphogenesis: current knowledge and emerging insights. Differentiation70, 227–246 (2002).
  • Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell67, 901–908 (1991).
  • Seol DW, Chen Q, Smith ML, Zarnegar R. Regulation of the c-met proto-oncogene promoter by p53. J. Biol. Chem.274, 3565–3572 (1999).
  • Boccaccio C, Ando M, Tamagnone L et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature391, 285–288 (1998).
  • Trovato M, d’Armiento M, Lavra L et al. Expression of p53/HGF/c-met/STAT3 signal in fetuses with neural tube defects. Virchows Arch.450, 203–210 (2007).
  • Amorosi S, d’Armiento M, Calcagno G et al. FOXN1 homozygous mutation associated with anencephaly and severe neural tube defect in human athymic Nude/SCID fetus. Clin. Genet.73, 380–384 (2008).
  • Jürgens G. Head and tail development of the Drosophyla embryo involves spalt, a novel homeotic gene. EMBO J.7, 189–196 (1988).
  • Kohlhase J, Wischermann A, Reichenbach H et al. Mutations in the SALL1 putative transcription factor gen causes Townes–Brocks syndrome. Nat. Genet.18, 81–83 (1998).
  • Powell CM, Michaelis RC. Townes–Brocks syndrome. J. Med. Genet.36, 89–93 (1999).
  • Kohlhase J, Chitayat D, Kotzot D et al. SALL 4 mutations in Okihiro syndrome, acro–renal–ocular syndrome and related disorders. Hum. Mutat.26, 176–183 (2005).
  • Böhm J, Buck A, Borozdin W et al. Sall1, Sall2 and Sall4 are required of neural tube closure in mice. Am. J. Pathol.173, 1455–1463 (2008).
  • Mackay DR, Hu M, Li B, Rheaume C, Dai X. The mouse Ovol2 gene is required for cranial tube development. Dev. Biol.291, 38–52 (2005).
  • Speman H, Mangold H. Induction of embryonic primordia by implantation of organizers from a different species 1923. Int. J. Dev. Biol.45, 13–38 (2001).
  • De Robertis EM, Larrain J, Oelgeschlager M, Wessely O. The establishment of Speman’s organizer and patterning of vertebrate embryo. Nat. Rev. Genet.1, 171–181 (2000).
  • Anderson RM, Stottmann RW, Choi M, Klingensmith J. Endogenous bone morphogenetic protein antagonists regulate mammalian neural crest generation and survival. Dev. Dyn.235, 2507–2520 (2006).
  • Larrain J, Bachiller D, Lu B, Agius E et al. BMP-binding modules in chordin: a model for signalling regulation in the extracellular space. Development127, 821–830 (2000).
  • Hawley SH, Wunnenberg-Stapleton K, Hashimoto C et al. Disruption of BMP signals in embryonic Xenopus ectoderm leads to direct neural induction. Genes Dev.9, 2923–2935 (1995).
  • Hemmati-Brivalou A, Kelly OG, Melton DA. Follistatin an antagonist of activin, expressed in the Spemann organizer and displays direct neuralizing activity. Cell77, 283–295 (1994).
  • Lamb TM, Knecht AK, Smith WC et al. Neural induction by secretide polypeptides. Science262, 713–718 (1993).
  • Bouwmester T, Kim SH, Sasai Y, Lu B, de Robertis EM. Cerberus is a head inducing secreted factor expressed in the anterior endoderm of Spemann’s organizer. Nature382, 595–601 (1996).
  • Hansen CS, Marion CD, Steele K et al. Direct neural induction and selective inhibition of mesoderm and epidermis inducers by Xnr3. Development124, 483–492 (1997).
  • Baird A, Bohlen P. Fibroblast growth factors. In: Peptide Growth Factors and their Receptors. Sporn NC, Roberts AB (Eds). Springer, Berlin, Germany and NY, USA, 369–418 (1990).
  • Streit A, Berliner AJ, Papanayotou C et al. Initiation of neural induction by FGF signalling before gastrulation. Nature406, 74–78 (2000).
  • Shi W, Peyrot SM, Munro E, Levine M. FGF3 in the floor plate directs notochord convergent extension in the Ciona tadpole. Development136, 23–28 (2009).
  • Nelson WJ, Nusse R. Convergence of Wnt, β-catenin and cadherin pathways. Science303, 1483–1487 (2004).
  • Pera EM, Wessely O, Li SY, de Robertis EM. Neural and head induction by insulin-like growth factor signals. Dev. Cell1, 655–665 (2001).
  • Zhang J, Li R, He Q et al. All-trans-retinoic acid alters Smads expression in embryonic neural tissue of mice. J. Appl. Toxicol. DOI: 10.1002/jat.1404 (2008) (Epub ahead of print)
  • Keller R. Shaping the vertebrate body plan by polarized embryonic cell movement. Science298, 1950–1954 (2002).
  • Wallingford JB, Rowning BA, Vogeli KM et al. Dishevelled controls cell polarity during Xenopus gastrulation. Nature405, 81–85 (2000).
  • Ciruna B, Jenny A, Lee D et al. AF. Planar cell polarity signaling couples cell division and morphogenesis during neurulation. Nature439, 220–224 (2006).
  • Wallingford JB. Neural tube closure and neural tube defects: studies in animal models reveal known knowns and known unknowns. Am. J. Med. Genet.135C, 59–68 (2005).
  • Cabrera RM, Hill DS, Etheredge AJ, Finnell RH. Investigations into the etiology of neural tube defects. Birth Defects Res. C Embryo Today72, 330–344 (2004).
  • Klein TJ, Mlodzik M. Planar cell polarization: an emerging model point in the right direction. Annu. Rev. Cell Dev. Biol.21, 155–176 (2005).
  • Tree DR, Ma D, Axelrod JD. A three-tiered mechanism for regulation of the planar cell polarity. Semin. Cell Dev. Biol.13, 217–224 (2002).
  • Jenny A, Reynolds-Kenneally J, Das G et al. Diego and prickle regulate frizzled planar cell polarity signaling by competing for disheveled binding. Nat. Cell Biol.7, 691–697 (2005).
  • Adler PN. Planar signaling and morphogenesis in Drosophila. Dev. Cell2, 525–535 (2002).
  • Habas R, Dawid IB. Dishevelled and Wnt signaling: is the nucleus the final frontier? J. Biol.4, 2–8 (2005).
  • Sokol SY. Analysis of Dishevelled signalling pathways during Xenopus development. Curr. Biol.6, 1456–1467 (1996).
  • Wallingford JB, Harland RM. Neural tube closure requires dishevelled-dependent convergent extension of the midline. Development129, 5815–5825 (2002).
  • Kibar Z, Vogan K, Groulx N et al. Ltap a mammalian homolog of Drosophila Strabismus/van Gogh, is altered in the mouse neural tube mutant loop-tail. Nat. Genet.28, 251–255 (2001).
  • Murdoch JN, Doudney K, Paternotte C et al. Severe neural tube defects in the loop-tail maouse result from the mutation of Lpp1, a novel gene involved in floor plate specification. Hum. Mol. Genet.10, 2593–2601 (2001).
  • Doudney K, Moore GE, Stanier P, Ybot-Gonzalez et al. Analysis of the planar cell polarity gene Vangl2 and its co-expressed paralogue Vangl1 in neural tube defects patients. Am. J. Med. Genet.136A, 90–92 (2005).
  • Goodrich LV. The plane facts of PCP in the CNS. Neuron60, 9–16 (2008).
  • Zallen JA. Planar polarity and tissue morphogenesis. Cell129, 1051–1063 (2007).
  • Kibar Z, Torban E, McDearmid JR et al. Mutations in VANGL1 associated with neural tube defects. N. Engl. J. Med.356, 1432–1437 (2007).
  • Wang J, Hamblet N, Mark S et al. Dishevelled genes mediate a conserved mammalian PCP pathway to regulate convergent extension during neurulation. Development133, 1767–1778 (2006).
  • Liu A, Wang B, Niswander LA. Mouse intraflagellar transport proteins regulate both the activator and the repressor functions of Gli transcription factors. Development132, 3103–3111 (2005).
  • Huangfu D, Anderson KV. Cilia and hedgehog responsiveness in mouse. Proc. Natl Acad. Sci. USA102, 11325–11330 (2005).
  • Chiang C, Litingtung Y, Lee E et al. Cyclopia and defective axial patterning in mice lacking sonic hedgehog gene function. Nature383, 407–413 (1996).
  • Smith UM, Consugar M, Tee LJ et al. The transmembrane protein meckelin (MKS3) is mutated in Meckel–Gruber syndrome and wpk rat. Nat. Genet.38, 191–196 (2006).
  • Loo CK, Freeman B, Wu XJ. N-CAM and keratins 7 and 20 in the ductal plate malformation of the Meckel–Gruber syndrome. Pathology38, 374–376 (2006).
  • Kyttala M, Tallila J, Salonen R et al. MKS1 encoding a component of the flagellar apparatus basal body proteome is mutated in Meckel syndrome. Nat. Genet.38, 155–157 (2006).
  • Holtfreter J, Hamburger V. Embryogenesis: progressive differentiation. In: Analysis of Development. Willier H, Weiss PA, Hamburger V (Eds). Saunders, PA, USA, 230–296 (1995).
  • Diez DC, Oliveira-Martinez I, Goriely A et al. Opposing FGF and retinoid pathways control ventral neural pattern, neuronal differentiation and segmentation during body axis extension. Neuron40, 5–79 (2003).
  • Novitch BG, Wichterle H, Jessel TM, Sockanathan S. A requirement for retinoic acid-mediated transcriptional activation in ventral neural patterning and motor neuron specification. Neuron40, 81–95 (2003).
  • Pierani A, Moran-Rivard L, Sunshine MJ et al. Control of interneuron fate in the developing spinal cord by the progenitor homeodomain protein Dbx1. Neuron29, 367–384 (2001).
  • Taylor NG. Identification of cellulose synthase AtCesA7 (IRX3) in vivo phosphorylation sites – a potential role in regulating protein degradation. Plant Mol. Biol.64, 161–171 (2007).
  • Lee KJ, Jessell TM. The specification of dorsal cell fates in the vertebrate central nervous system. Annu. Rev. Neurosci.22, 261–294 (1999).
  • Pierani A, Brenner-Morton S, Chiang C, Jessell TM. A sonic hedgehog independent, retinoic activated pathway of neurogenesis in the ventral spinal cord. Cell97, 903–915 (1999).
  • Stoykova A, Gruss P. Roles of Pax-genes in developing and adult brain as suggested by expression patterns. J. Neurosci.14, 1395–1412 (1994).
  • Chalepakis G, Fritsch R, Fickenscher H et al. The molecular basis of the undulated/Pax-1 mutation. Cell66, 873–884 (1991).
  • Tassabehji M, Read AP, Newton VE et al. Mutation in the PAX3 gene causing Waardenburg syndrome type 1 and type 2. Nat. Genet.3, 26–30 (1993).
  • Baldwin CT, Lipsky NR, Hoth CF et al. Mutations in PAX3 gene causing Waardenburg syndrome type I. Hum. Mutat.3, 205–211 (1994).
  • Burren KA, Savery D, Massa V, Kok RM. Gene–environment interactions in the causation of neural tube defects: folate deficiency increases susceptibility conferred by loss of Pax3 function. Hum. Mol. Genet.17, 3675–3686 (2008).
  • Hol FA, Geurds MP, Chatkupt S et al. PAX genes and human neural tube defects: an amino acid substitution in PAX1 in a patient with spina bifida. J. Med. Genet.33, 655–660 (1996).
  • Nieuwkoop PD, Weijer CJ. Neural induction a two-way process. Med. Biol.56, 366–371 (1978).
  • Slack JM. Developmental biology. Growth factor lends a hand. Nature374, 217–218 (1995).
  • Sive HL, Hattori K, Weintraub H. Progressive determination during formation of the anteroposterior axis in Xenopus laevis. Cell58, 171–180 (1989).
  • Durston AJ, Timmermans JP, Hage WJ et al. Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature340, 140–144 (1989).
  • Altaba A, Jessell T. Retinoic acid modifies mesodermal patterning in early Xenopus embryos. Genes Dev.5, 175–187 (1991).
  • Papalopulu N, Kintner C. A posteriorising factor, retinoic acid, reveals that anteroposterior patterning controls the timing of neuronal differentiation in Xenopus neuroectroderm. Development122, 3409–3418 (1996).
  • Shiotsugu J, Katsuyama Y, Arima K et al. Multiple points of interaction between retinoic acid and FGF signaling during embryonic axis formation. Development131, 2653–2667 (2004).
  • Wild A, Kalff-Suske M, Vortkamp A et al. Point mutations in human GLI3 cause Greig syndrome. Hum. Mol. Genet.6, 1979–1984 (1997).
  • Radhakrishna U, Wild A, Grzeschik KH, Antonarakis SE. Mutation in GLI3 in postaxial polydactyly type A. Nat. Genet.17, 269–271 (1997).
  • Warkany J, Petering HG. Congenital malformation of the central nervous system in rats produced by maternal zinc deficiency. Teratology5, 319–334 (1972).
  • Cavdar AO, Bahceci M, Akar N et al. Zinc status in pregnancy and the occurrence of anencephaly in Turkey. J. Trace Elem Electrolytes Health Dis.2, 9–14 (1988).
  • Brenton DP, Jackson MJ, Young A. Two pregnancies in a patient with acrodermatitis enteropathica treated with zinc sulphate. Lancet2, 500–502 (1981).
  • Nagai T, Aruga J, Takada S et al. The expression of the mouse Zic1, Zic2, Zic3 gene suggest an essential role for Zic genes in body pattern formation. Dev. Biol.182, 299–313 (1997).
  • Klootwijk R, Groenen P, Schijvenaars M et al. Genetic variants in ZIC1, ZIC2 and ZIC3 are not major risk factors for neural tube defects in humans. Am. J. Med. Genet.124A, 40–47 (2004).
  • Aruga J, Minowa O, Yaginuma H et al. Mouse Zic1 is involved in cerebellar development. J. Neurosci.18, 284–293 (1998).
  • Zhu H, Lu W, Laurent C et al. Genes encoding catalytic subunits of protein kinase A and risk of spina bifida. Birth Defects Res. A Clin. Mol. Teratol.73, 591–596 (2005).
  • Biggs PJ, Warren W, Venitt S, Straton MR. Does a genotoxic carcinogene contribute to human breast cancer? The value of mutational spectra in unraveling the etiology of cancer. Mutagenesis8, 275–283 (1993).
  • Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppresor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res.54, 4855–4878 (1994).
  • Pangilinan F, Geiler K, Dolle J et al. Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation TP53 and neural tube defect risk in an Irish population. Am. J. Med. Genet.146A, 2617–2625 (2008).
  • Rutishauser U, Jessell TM. Cell adhesion molecules in vertebrate neural development. Physiol. Rev.68, 819–885 (1988).
  • Detrick RJ, Dickey D, Kinter CR. The effects of N-cadherin misexpression on morphogenesis in Xenopus embryos. Neuron4, 493–506 (1990).
  • Warga RM, Kane DA. A role for N-cadherin in mesodermal morphogenesis during gastrulation. Dev. Biol.310, 211–225 (2007).
  • Thiery JP, Duband JL, Rutishauser U, Edelman GM. Cell adhesion molecules in early chicken embryogenesis. Proc. Natl Acad. Sci.79, 6737–6741 (1982).
  • Edelman GM. Cell adhesion molecules Science219, 450–457 (1983).
  • Deak KL, Boyles AL, Etchevesr HC et al. SNPs in the neural cell adhesion molecule 1 (NCAM1) gene may be associated with human neural tube defects. Hum. Genet.117, 133–142 (2005).
  • Hibbard ED, Smithells RW. Folic acid metabolism and human embryopathy. Lancet1, 1254–1258 (1965).
  • Smithells RW, Neven NC, Seller MJ. Further experience of vitamin supplementation for prevention of neural tube defects recurrences. Lancet1(8332), 1027–1030 (1983).
  • Mulinare J, Cordero JF, Erikson JD. Periconceptional use of multivitamins and the occurence of neural tube defects. JAMA260, 3141–3145 (1988).
  • Nijhout HF, Reed MC, Budu P, Ulrich CM. A mathematical model of the folate cycle: new insights into folate homeostasis. J. Biol. Chem.79, 55008–55016 (2004).
  • O’Leary VB, Mills JL, Parle-McDermott A et al. Screening for new MTHFR polymorphisms and NTD risk. Am. J. Med. Genet.138A, 99–106 (2005).
  • O’Leary VB, Pangilinan F, Cox C et al. Reduced folate carrier polymorphisms and neural tube defect risk. Mol. Genet. Metab.87, 364–369 (2006).
  • Brouns R, Ursem N, Lindemans J et al. Polymorphisms in genes related to folate and cobalamin metabolism and the associations with complex birth defects. Prenat. Diagn.28, 485–493 (2008).
  • Kapusta L, Haagmans ML, Steegers EA et al. Congenital heart defect and maternal derangement of homocysteine metabolism. J. Pediatr.135, 773–774 (1999).
  • Dalal A, Pradhan M, Tiwari D et al. MTHFR 677C>T and 1298A>C polymorphisms: evaluation of maternal genotypic risk and associaton with level of neural tube defects. Gynecol. Obstet. Invest.63, 146–150 (2007).
  • Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet.10, 111–113 (1995).
  • Fodinger M, Horl WH, Sunder-Plassman G. Molecular biology of 5,10-methyelenetetrahydrofolate reductase. J. Nephrol.13, 20–33 (2000).
  • Johnson WG, Stenroos ES, Spychala JR et al. New 19 bp deletion polymorphism in intron-1 of dihidrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am. J. Med. Genet.124A, 339–345 (2004).
  • Guerin SL, Leclerc S, Verreault H et al. Overlapping cis-acting elements located in the first intron of the gene for type I 3 β-hydroxysteroid dehydrogenase modulate its transcriptional activity. Mol. Endocrin.9, 1583–1597 (1995).
  • Clark IM, Rowan AD, Edwards DR et al. Transcriptional activity of the human tissue inhibitor of metalloproteinase 1 (TIMP1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem. J.324, 611–617 (1997).
  • Boyles AL, Billups AV, Deak KL et al. Neural tube defects and folate pathway genes: family based association tests of gene-gene and gene-environment interactions. Environ. Health Perspect.114, 1547–1552 (2006).
  • Gelineau-van Waes J, Maddox JR, Smith LM et al. Microarray analysis of E9.5 reduced folate carrier (RFC1; Slc19a1) knockout embryos reveals altered expression of genes in the cubilin-megalin multiligand endocytic receptor complex. BMC Genomics9, 156–161 (2008).
  • Rothenberg SP, da Costa MP, Sequeira JM et al. Autoantibodies against folate receptors in women with a pregnancy complicated by neural tube defect. N. Engl. J. Med.350, 134–142 (2004).
  • Epstein DJ, Vekemans M, Gros P. Splotch (Sp2H) a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax3. Cell67, 767–774 (1991).
  • Mitrecić D, Mavrić S, Gajović S. PCR-based identification of short deletion/insertions and single nucleotide substitutions in genotyping of splotch (Pax3sp) and truncate (Nototc) mouse mutants. Mol. Cell Probes22, 110–114 (2008).
  • Wlodarczyk BJ, Tang LS, Triplett A et al. Spontaneous neural tube defects in splotch mice supplemented with selected micronutrients. Toxicol. Appl. Pharmacol.15, 55–63 (2006).
  • Kuhar SG, Feng L, Vidan S et al. Changing patterns of gene expression define four stages of cerebellar granule neuron differentiation. Development117, 97–104 (1993).
  • Kutzbach C, Stokstad EL. 10-formyltetrahydrofolate: NADP oxireductase. Methods Enzymol.18B, 793–798 (1971).
  • Krebs HA, Hems R, Tyler B. The regulation of folate and methionine metabolism. Biochem. J.158, 341–353 (1976).
  • Scrutton MC, Beis I. Inhibitory effects of histidine and their reversal. The roles of pyruvate carboxylase and N10-formyltetrahydrofolate dehydrogenase. Biochem. J.177, 833–846 (1979).
  • Anthony TE, Heintz N. The folate metabolic enzyme ALDH1L1 is restricted to the midline of the early CNS suggesting a role in human neural tube defects. J. Comp. Neurol.500, 368–383 (2007).
  • Detrait ER, George TM, Etchevers HC et al. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol. Teratol.27, 515–524 (2005).
  • Nakatsu T, Uwabe C, Shiota K. Neural tube closure in humans initiates at multiple sites: evidence from human embryos and implications for the pathogenesis of neural tube defects. Anat. Embryol. (Berl.)201, 455–466 (2000).
  • Jones C, Chen P. Planar cell polarity signaling in vertebrates. BioEssays29, 120–132 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.